Revolution Medicines, Inc. RVMDW

Peg Horn — Investor Relations

Mark Goldsmith — Chairman and Chief Executive Officer

Jack Anders — Senior Vice President of Finance and Principal Accounting Officer

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RVMDW calls or request research access.

More RVMDW calls Browse calls Request research access